4 Einträge gefunden

1. Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis

   1. Wenzel, Mike
   2. Würnschimmel, Christoph
   3. Nocera, Luigi
   4. Collà Ruvolo, Claudia
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Saad, Fred

   2022 - Forschungsinformationssystem des UKE
2. Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

   1. Wenzel, Mike
   2. Nocera, Luigi
   3. Collà Ruvolo, Claudia
   4. Würnschimmel, Christoph
   5. Tian, Zhe
   6. Shariat, Shahrokh F
   7. Saad, Fred

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysis

   1. Wenzel, Mike
   2. Deuker, Marina
   3. Nocera, Luigi
   4. Collà Ruvolo, Claudia
   5. Würnschimmel, Christoph
   6. Tian, Zhe
   7. Shariat, Shahrokh F

   2021 - Forschungsinformationssystem des UKE
4. Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

   1. Gallina, Andrea
   2. Jeldres, Claudio
   3. Chun, Felix
   4. Shariat, Shahrokh F
   5. Briganti, Alberto
   6. Walz, Jochen
   7. Roehrborn, Claus G

   2007 - Forschungsinformationssystem des UKE